IntegriChain

Join us for a deep dive into BFSF and FMV with Nicholas Lynch, CFE on October 15 at 9:55 AM during our Access Insights Conference. Discover how to streamline your government pricing and ensure compliance. Register today: https://lnkd.in/eYB8irsw

Chetan Mahajan is a valued leader in our product and technology team! He is critical to the team, transforming product vision into application delivery. Chetan understands the critical processes for pharma commercialization, and ensures our SaaS and BPaaS solutions meet the mark. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/d6B_eKm

Don't miss our session on Challenges in Assessing Demand on October 15 at 3:25 PM during our Access Insights Conference. Aaron Light, Haley Morgaylo, and David Weiss will discuss the latest trends and techniques for accurately understanding patient demand. Register today: https://lnkd.in/eYB8irsw

Join us for a deep dive into IRA negotiation best practices at the Medicaid Drug Rebate Program Summit. On September 24th at 10:55 AM Partner of IntegriChain, Jeffrey Baab, and Partner of Arnold & Porter, Kristin Hicks, will share critical insights on: -Navigating the IRA negotiation process and timeline -Overcoming portal challenges -Deciphering the implications of final MFPs for CMS discount justification -Best practices for documentation and data preparation Identifying high-risk drugs for selection Don't miss this opportunity to gain a competitive edge in the evolving pharmaceutical landscape: https://lnkd.in/dfJQ7AqD

We are honored to have such an esteemed panel representing retail pharmacy at our Access Insights Conference. Thank you, Douglas Hoey of National Community Pharmacists Association, Patrick Lupo of Walgreens, Sarit Roy of OnPoint Pharmacy, and Lisa Smith of Walmart for being part of our Executive Summit thought leadership program. Now in its 15th year and co-hosted by IntegriChain, Blue Fin Group, an IntegriChain Company, and Federal Compliance Solutions, an IntegriChain Company, the 3-day Access Insights is the only conference in the Pharma industry that is truly full commercialization across all the therapeutic areas, product archetypes, and benefit constructs. It's considered a can't-miss event for understanding the implications of recent and forward-looking public policy, commercial insurance, and how the sites of care, GPOs, and distribution channels contend or influence the market plus the latest in channel strategy and the patient journey, net revenue forecasting and planning, new product archetype commercialization and so much more. Check out our agenda and register today for Access Insights: https://lnkd.in/eYB8irsw

We welcome Matt Heyman as our new Chief Financial Officer to lead our global finance organization. CEO Joshua Halpern said: “We are thrilled to have Matt join us with his depth of experience in corporate finance and development, growing SaaS companies, and partnering with strategic investors.” Read more here: https://bit.ly/3XbFK2c

Branded drug costs have been on a steady climb for years, but 2024 has thrown a curveball with significant wholesale acquisition cost reductions. Join us tomorrow for the second webinar in our three-part series as we dissect these surprising price cuts and analyze them against historical trends. Don’t miss this opportunity to understand the full impact of these changes: https://lnkd.in/eNb8iyti

Unlock the secrets to accurate net revenue forecasting and planning. Learn from industry experts at our Access Insights Conference from October 14 to 16. Check out our agenda and register today: https://lnkd.in/eYB8irsw

Richard Moore is the valued leader of our Federal Compliance Solutions team! He helps clients navigate complexity by providing expert knowledge and insight in the areas of Commercial and Government Pricing compliance, Contracting, Gross-to-Net, Compliance, and M&A support. We are honored to have him under our IntegriChain umbrella as a trusted advisor to manufacturers of all sizes and types – including 40+ emerging pharma manufacturers. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/d6B_eKm

For years, branded drug costs have risen consistently. Yet, 2024 has brought a surprising shift with substantial decreases in wholesale acquisition costs. Our second webinar in a three-part series will explore the extraordinary depth of these price cuts in the context of historical data. Don't miss out: https://lnkd.in/eNb8iyti